<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7589085" created="30/05/2006" creator="Junko Matsuura"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7589085</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="T1" lex="CD30_ligation" sem="Other"><term id="T2" lex="CD30" sem="Protein_molecule">CD30</term> ligation</term> induces <term id="T3" lex="nuclear_factor-kappa_B_activation" sem="Other"><term id="T4" lex="nuclear_factor-kappa_B" sem="Protein_complex">nuclear factor-kappa B</term> activation</term> in <term id="T5" lex="human_T_cell_line" sem="Cell_cultured">human T cell lines</term>.</sentence>
<event id="E1">
<type class="Positive_regulation"/>
<theme idref="T4"/>
<clue>CD30 ligation induces nuclear factor-kappa B <clueType>activation</clueType> in human T cell lines.</clue>
</event>
<event id="E2">
<type class="Binding"/>
<theme idref="T2"/>
<clue>CD30 <clueType>ligation</clueType> induces nuclear factor-kappa B activation in human T cell lines.</clue>
</event>
<event id="E3">
<type class="Positive_regulation"/>
<theme idref="E1"/>
<cause idref="E2"/>
<clue>CD30 ligation <clueType>induces</clueType> nuclear factor-kappa B activation <clueLoc>in human T cell lines.</clueLoc></clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2"><term id="T6" lex="CD30" sem="Protein_molecule">CD30</term> is a recently described member of the <term id="T7" lex="tumor_necrosis_factor/nerve_growth_factor_receptor_superfamily" sem="Protein_family_or_group"><term id="T8" lex="tumor_necrosis_factor" sem="Protein_molecule">tumor necrosis factor</term><term id="T9" lex="nerve_growth_factor" sem="Protein_domain_or_region">/nerve growth factor</term> receptor superfamily</term>.</sentence>
<sentence id="S3">In this report, we show that following incubation of <term id="T10" lex="L540_cell" sem="Cell_cultured">L540 cells</term> (<term id="T11" lex="Hodgkin&apos;s_disease-derived,_T_cell-like,_CD30+_cell" sem="Cell_cultured"><term id="T12" lex="Hodgkin&apos;s_disease" sem="Other">Hodgkin&apos;s disease</term>-derived, T cell-like, <term id="T13" lex="CD30" sem="Protein_molecule">CD30</term>+ cells</term>) with the <term id="T14" lex="agonistic_anti-CD30_monoclonal_antibody" sem="Protein_family_or_group">agonistic anti-<term id="T15" lex="CD30" sem="Protein_molecule">CD30</term> monoclonal antibodies</term> (<term id="T16" lex="mAb" sem="Protein_family_or_group">mAb</term>) <term id="T17" lex="M44" sem="Protein_molecule">M44</term> and <term id="T18" lex="M67" sem="Protein_molecule">M67</term>, two <term id="T19" lex="nuclear_factor_(NF)-kappa_B_DNA_binding_activity" sem="Other"><term id="T20" lex="nuclear_factor_(NF)-kappa_B" sem="Protein_molecule">nuclear factor (NF)-kappa B</term> <term id="A1" sem="DNA_molecule">DNA</term> binding activities</term> were induced in <term id="T21" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term>, as determined in <term id="T22" lex="gel_retardation_assay" sem="Other">gel retardation assays</term>.</sentence>
<event id="E4">
<type class="Binding"/>
<theme idref="T20"/>
<theme idref="A1"/>
<clue>In this report, we show that following incubation of L540 cells (Hodgkin&apos;s disease-derived, T cell-like, CD30+ cells) with the agonistic anti-CD30 monoclonal antibodies (mAb) M44 and M67, two nuclear factor (NF)-kappa B DNA <clueType>binding activities</clueType> were induced in nuclear extracts, as determined in gel retardation assays.</clue>
</event>
<event id="E5">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T17"/>
<clue>In this report, we <clueKT>show</clueKT> that following incubation of <clueLoc>L540 cells (Hodgkin&apos;s disease-derived, T cell-like, CD30+ cells)</clueLoc> <linkCause>with</linkCause> the agonistic anti-CD30 monoclonal antibodies (mAb) M44 and M67, two nuclear factor (NF)-kappa B DNA binding activities were <clueType>induced</clueType> in nuclear extracts, <clueExperiment>as determined in gel retardation assays.</clueExperiment></clue>
</event>
<event id="E6">
<type class="Positive_regulation"/>
<theme idref="E4"/>
<cause idref="T18"/>
<clue>In this report, we <clueKT>show</clueKT> that following incubation of <clueLoc>L540 cells (Hodgkin&apos;s disease-derived, T cell-like, CD30+ cells)</clueLoc> <linkCause>with</linkCause> the agonistic anti-CD30 monoclonal antibodies (mAb) M44 and M67, two nuclear factor (NF)-kappa B DNA binding activities were <clueType>induced</clueType> in nuclear extracts, <clueExperiment>as determined in gel retardation assays.</clueExperiment></clue>
</event>
<sentence id="S4">The effect of the <term id="T23" lex="mAb" sem="Protein_family_or_group">mAb</term> towards <term id="T24" lex="NF-kappa_B_activation" sem="Other"><term id="T25" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> was rapid, as it occurred within 20 min, and was sustained for up to 6 h.</sentence>
<event id="E7">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<clue>The effect of the mAb towards NF-kappa B <clueType>activation</clueType> was rapid, as it occurred within 20 min, and was sustained for up to 6 h.</clue>
</event>
<event Manner="High" id="E52">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<cause idref="T17"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the mAb</corefCause> <linkTheme>towards</linkTheme> NF-kappa B activation was <clueManner>rapid</clueManner>, as it occurred <clueTime>within 20 min</clueTime>, and was sustained for up to 6 h.</clue>
</event>
<event Manner="High" id="E53">
<type class="Positive_regulation"/>
<theme idref="T25"/>
<cause idref="T18"/>
<clue>The <clueType>effect</clueType> <linkCause>of</linkCause> <corefCause>the mAb</corefCause> <linkTheme>towards</linkTheme> NF-kappa B activation was <clueManner>rapid</clueManner>, as it occurred <clueTime>within 20 min</clueTime>, and was sustained for up to 6 h.</clue>
</event>
<sentence id="S5">By comparison, an <term id="T26" lex="isotype-matched_antibody" sem="Protein_family_or_group">isotype-matched antibody</term> had no effect on <term id="T27" lex="NF-kappa_B_activation" sem="Other"><term id="T28" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term>.</sentence>
<event id="E8">
<type class="Positive_regulation"/>
<theme idref="T28"/>
<clue>By comparison, an isotype-matched antibody had no effect on NF-kappa B <clueType>activation</clueType>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E9">
<type class="Regulation"/>
<theme idref="E8"/>
<cause idref="T26"/>
<clue>By comparison, an isotype-matched antibody had <cluePolarity>no</cluePolarity> <clueType>effect</clueType> <linkTheme>on</linkTheme> NF-kappa B activation.</clue>
</event>
<sentence id="S6">Moreover, in <term id="T29" lex="human_T_helper_(Th)_clone" sem="Cell_cultured">human T helper (Th) clones</term> functionally characterized as being of the type 0, type 1 and type 2 (28%, &lt; 1% und 93% CD30+, respectively), the extent of <term id="T31" lex="CD30" sem="Protein_molecule">CD30</term>-mediated <term id="T32" lex="NF-kappa_B_activation" sem="Other"><term id="T33" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> activation</term> correlated with the <term id="A2" sem="Other">proportion of <term id="T34" lex="CD30+_cell" sem="Cell_cultured">CD30+ cells</term></term>.</sentence>
<event KT="Other" id="E10">
<type class="Positive_regulation"/>
<theme idref="T33"/>
<cause idref="T31"/>
<clue>Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, &lt; 1% und 93% CD30+, respectively), the extent of CD30-<linkCause>mediated</linkCause> NF-kappa B <clueType>activation</clueType> correlated with the proportion of CD30+ cells.</clue>
<comment>NER: T30 del &quot;CD30-mediated NF-kappa B activation&quot;</comment></event>
<event KT="Analysis" id="E300">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="A2"/>
<clue>Moreover, <clueLoc>in human T helper (Th) clones functionally characterized as being of the type 0</clueLoc>, type 1 and type 2 (<clueLoc>28%</clueLoc>, &lt; 1% und 93% <clueLoc>CD30+</clueLoc>, respectively), the extent of CD30-mediated NF-kappa B activation <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the proportion of CD30+ cells.</clue>
<comment>TPS: A2</comment></event>
<event KT="Analysis" id="E301">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="A2"/>
<clue>Moreover, <clueLoc>in human T helper (Th) clones functionally characterized as being of the</clueLoc> type 0, <clueLoc>type 1</clueLoc> and type 2 (28%, <clueLoc>&lt; 1%</clueLoc> und 93% <clueLoc>CD30+</clueLoc>, respectively), the extent of CD30-mediated NF-kappa B activation <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the proportion of CD30+ cells.</clue>
<comment>TPS: A2</comment></event>
<event KT="Analysis" id="E302">
<type class="Correlation"/>
<theme idref="E10"/>
<theme idref="A2"/>
<clue>Moreover, <clueLoc>in human T helper (Th) clones functionally characterized as being of the</clueLoc> type 0, type 1 and <clueLoc>type 2</clueLoc> (28%, &lt; 1% und <clueLoc>93% CD30+</clueLoc>, respectively), the extent of CD30-mediated NF-kappa B activation <clueType><clueKT>correlated</clueKT></clueType> <linkTheme>with</linkTheme> the proportion of CD30+ cells.</clue>
<comment>TPS: A2</comment></event>
<sentence id="S7">In all cell lines investigated, the <term id="T35" lex="NF-kappa_B_complex" sem="Protein_complex"><term id="T36" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> complexes</term> induced following <term id="T37" lex="CD30_engagement" sem="Other"><term id="T38" lex="CD30" sem="Protein_molecule">CD30</term> engagement</term> were shown to contain <term id="T39" lex="p50_NF-kappa_B1" sem="Protein_molecule">p50 NF-kappa B1</term>, <term id="T40" lex="p65_RelA" sem="Protein_molecule">p65 RelA</term>, and possibly other <term id="T41" lex="transcription_factor" sem="Protein_family_or_group">transcription factors</term>.</sentence>
<event id="E12">
<type class="Binding"/>
<theme idref="T38"/>
<clue>In all cell lines investigated, the NF-kappa B complexes induced following CD30 <clueType>engagement</clueType> were shown to contain p50 NF-kappa B1, p65 RelA, and possibly other transcription factors.</clue>
</event>
<event id="E13">
<type class="Positive_regulation"/>
<theme idref="T35"/>
<cause idref="E12"/>
<clue>In all cell lines investigated, the NF-kappa B complexes <clueType>induced</clueType> <linkCause>following</linkCause> CD30 engagement were shown to contain p50 NF-kappa B1, p65 RelA, and possibly other transcription factors.</clue>
</event>
<sentence id="S8">Collectively, our results demonstrate that nuclear translocation and activation of <term id="T42" lex="NF-kappa_B" sem="Protein_molecule">NF-kappa B</term> rank among the <term id="T43" lex="short-term_cellular_response" sem="Other">short-term cellular responses</term> elicited following <term id="T44" lex="CD30_ligation" sem="Other"><term id="T45" lex="CD30" sem="Protein_molecule">CD30</term> ligation</term>.</sentence>
<event KT="Other" id="E16">
<type class="Positive_regulation"/>
<theme idref="T42"/>
<clue>Collectively, our results demonstrate that nuclear translocation and <clueType>activation</clueType> <linkTheme>of</linkTheme> NF-kappa B rank among the short-term cellular responses elicited following CD30 ligation.</clue>
</event>
<event KT="Other" id="E17">
<type class="Localization"/>
<theme idref="T42"/>
<clue>Collectively, our results demonstrate that <clueLoc>nuclear</clueLoc> <clueType>translocation</clueType> and activation <linkTheme>of</linkTheme> NF-kappa B rank among the short-term cellular responses elicited following CD30 ligation.</clue>
</event>
<event KT="Other" id="E18">
<type class="Binding"/>
<theme idref="T45"/>
<clue>Collectively, our results demonstrate that nuclear translocation and activation of NF-kappa B rank among the short-term cellular responses elicited following CD30 <clueType>ligation</clueType>.</clue>
</event>
<event KT="Analysis" id="E19">
<type class="Positive_regulation"/>
<theme idref="E16"/>
<cause idref="E18"/>
<clue>Collectively, our results <clueKT>demonstrate</clueKT> that nuclear translocation and activation of NF-kappa B rank among the short-term cellular responses <clueType>elicited</clueType> <linkCause>following</linkCause> CD30 ligation.</clue>
</event>
<event KT="Analysis" id="E20">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="E18"/>
<clue>Collectively, our results <clueKT>demonstrate</clueKT> that nuclear translocation and activation of NF-kappa B rank among the short-term cellular responses <clueType>elicited</clueType> <linkCause>following</linkCause> CD30 ligation.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
